
    
      3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors (statins) have been shown to
      reduce local and systemic inflammation in animal models of various autoimmune disorders
      including uveitis. In this open-label, randomized study clinical efficacy and tolerability of
      simvastatin 40 mg/day for 8 weeks is evaluated.
    
  